Twice as many patients treated in Europe because of generic medicine

“Medicines for Europe” strongly supports the French government campaign to boost generic medicines. Thanks to generic medicines, in Europe twice as many patients in 7 key therapeutic areas [1] (diabetes, depression, epilepsy, cardiovascular disease, hypertension, asthma/COPD, gastro-intestinal disease) have been able to be treated over the last ten years with no impact on overall treatment costs.

On the 30^th September “Zdravi” joined again the global initiative PARK(ing) Day. Parts of the parking spaces in Sofia were transformed into public spaces for people. Everyone had the chance to take part in writing “Life is good when we are healthy” by taking a photo with a letter of their liking and participating in the game of the application. As host #Zdravi usually challenges its visitors to do something good for themselves – to work out there, to test their minds or to stay hydrated with water and tea.

SOPHARMA AD hereby informs that as a result of its intention to express interest in acquiring a commercial company operating on the territory of the Republic of Moldova, as a first step Sopharma AD filed a request for approval of concentration with the competent authorities in the Republic of Moldova.

For the first nine months of this year, revenues from sales decreased by 3% compared to the same period of 2015, including 1% increase of domestic sales and a 5% decrease of export sales. “We are witnessing a positive trend in September, but it is hard to forecast whether it will be stable. However, we managed to a certain extent to compensate the weaker performance of the Russian market in the first half of this year.”, comments Ognian Donev, PhD, Chariman of the Board of Directors and Executive director of Sopharma AD.

We would like to notify that Board of directors of Sopharma AD discussed a proposal filed by Homogen AD on October 4, 2016 for the sale of shares from the capital of Veta Farma AD. The Board of directors of Sopharma AD authorizes the Executive director to negotiate with representatives of the seller.

SOPHARMA AD hereby informs that from 29 September 2016 up to and including 30 September 2016 the Company bought 57 328 own shares representing 0.027% of the share capital of the Company, at a total value of 171 228.54 BGN on the Bulgarian Stock Exchange, the average price per share was 2.99 BGN. T

he trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 662 414, representing 4.20% of the share capital of the Company.

SOPHARMA AD hereby informs that from 27 September up to and including 28 September 2016 the Company bought 97 705 own shares representing 0.07% of the share capital of the Company, at a total value of 285 115.51 BGN on the Bulgarian Stock Exchange, the average price per share was 2.91 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 605 086, representing 4.16% of the share capital of the Company.

SOPHARMA AD hereby informs that from 15 September up to and including 26 September 2016 the Company bought 27 669 own shares representing 0.02% of the share capital of the Company, at a total value of 77 250.62 BGN on the Bulgarian Stock Exchange, the average price per share was 2.79 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 507 381, representing 4.085% of the share capital of the Company.

Уведомяваме Ви, че на 7 октомври, 2016 година (петък) Софарма АД организира Годишна среща с инвеститорите, на която ще бъде представена и новата интернет страница на Група Софарма. Срещата ще се проведе в конферентния център на Софарма Бизнес Тауърс, гр. София. Каним всички заинтересовани лица да заявят желание за участие до 30 септември, 2016 година на електронен адрес irevents@sopharma.bg или на телефон (02) 8134 319, за да получат регистрационна форма.

Местата са ограничени.